ESTROPA Trademark

Trademark Overview

On Friday, September 30, 2011, a trademark application was filed for ESTROPA with the United States Patent and Trademark Office. The USPTO has given the ESTROPA trademark a serial number of 85436512. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 25, 2015. This trademark is owned by Glaxo Group Limited. The ESTROPA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
estropa

General Information

Serial Number85436512
Word MarkESTROPA
Filing DateFriday, September 30, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 25, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 28, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 6, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Tuesday, May 26, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 25, 2015ABANDONMENT - NO USE STATEMENT FILED
Saturday, October 4, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 3, 2014EXTENSION 5 GRANTED
Wednesday, October 1, 2014EXTENSION 5 FILED
Wednesday, October 1, 2014TEAS EXTENSION RECEIVED
Thursday, April 17, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 16, 2014EXTENSION 4 GRANTED
Monday, April 14, 2014EXTENSION 4 FILED
Monday, April 14, 2014TEAS EXTENSION RECEIVED
Tuesday, October 22, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 21, 2013EXTENSION 3 GRANTED
Monday, October 14, 2013EXTENSION 3 FILED
Monday, October 14, 2013TEAS EXTENSION RECEIVED
Tuesday, April 9, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 8, 2013EXTENSION 2 GRANTED
Friday, April 5, 2013EXTENSION 2 FILED
Friday, April 5, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 11, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 10, 2012EXTENSION 1 GRANTED
Monday, October 8, 2012EXTENSION 1 FILED
Wednesday, October 10, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 8, 2012TEAS EXTENSION RECEIVED
Tuesday, April 24, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 28, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 28, 2012PUBLISHED FOR OPPOSITION
Wednesday, February 8, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 26, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 25, 2012ASSIGNED TO LIE
Saturday, January 7, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 6, 2012ASSIGNED TO EXAMINER
Thursday, October 6, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, October 4, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

estropa pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological